Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patientsChun‐Nan Yeh, Ming‐Huang Chen|Oncotarget|2017Cited by 20
HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomyChun‐Nan Yeh, Kun‐Chun Chiang|Cancer Management and Research|2018Cited by 17
ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent MannerYi‐Ru Pan, Chun‐Nan Yeh|Biomolecules|2020Cited by 12
MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patientsChi‐Tung Cheng, Chun‐Nan Yeh|Oncology Reports|2018Cited by 7
Abstract 1309: Identification of aurora kinase a as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumorsChun‐Nan Yeh, Jonathan A. Fletcher, Yeng-Yang Chen et al.|Cancer Research|2014Cited by 0